Neovacs S.A. Announced earnings results for the half year ended June 30, 2019. For the half year, the company announced sales was EUR 264,000 compared to EUR 19,000 a year ago. Operating loss was EUR 4.619 million compared to EUR 6.621 million a year ago. Net loss was EUR 3.752 million compared to EUR 6.096 million a year ago.